Finance

Lists
INGN:NASDAQ
Inogen Inc
$5.69
+1.25%
(+0.070) 1D
Nov 13, 4:00:01 PM GMT-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for INGN...
Open
$5.60
High
$5.71
Low
$5.55
Mkt. cap
147.95M
Avg. vol.
301.99K
Volume
238.18K
52-wk high
$7.67
52-wk low
$5.04
EPS
-$0.90
Beta
1.51
Shares outstanding
26.00M
No. of employees
753
Open
$5.60
High
$5.71
Low
$5.55
Mkt. cap
147.95M
Avg. vol.
301.99K
Volume
238.18K
52-wk high
$7.67
52-wk low
$5.04
EPS
-$0.90
Beta
1.51
Shares outstanding
26.00M
No. of employees
753
News stories
From web sources and news partners
About Inogen Inc
CEOKevin R. Smith
Employees753
Founded2001
HeadquartersGoleta, California, United States
SectorHealth Care
IndustryMedical device
Analyst ratings
Based on 2 analysts giving stock ratings to INGN in the past 3 months
Buy
Buy
2
Hold
0
Sell
0
12-month forecast
Based on 2 Wall Street analysts offering 12 month price targets for INGN in the last 3 months.
Highest
Current $5.69
$12.00 (+110.90%)
Average
$10.75 (+88.93%)
Lowest
$9.50 (+66.96%)
Analyst
Recommendation
Action
Price target
Projected
Date
Ilya Zubkov
Freedom Capital Markets
Buy
Maintained
$9.50
+67%
11/10/2026
Michael Matson
Needham
Buy
Maintained
$12.00
+110.9%
10/01/2026
Unknown Analyst
B. Riley Securities
Buy
Initiated
$14.00
+146%
08/07/2026
Anderson Schock
B. Riley Securities
Buy
Reiterated
$14.00
+146%
01/21/2026
Last report
Nov 5, 2026
Fiscal period
Q3 2026
-$0.02 / -$0.06
+66.67%beat
Revenue / Est. (USD)
77.19M / 92.25M
-16.32%miss
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
81.72M
85.11M
95.08M
77.19M
Cost of goods sold
46.48M
47.25M
-
43.18M
Cost of revenue
46.48M
47.25M
-
43.18M
Research and development expenses
5.32M
5.10M
-
5.40M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
39.23M
41.18M
-
32.80M
Operating expense
44.54M
46.28M
-
38.21M
Total operating expenses
91.03M
93.53M
-
81.39M
Operating income
-9.31M
-8.42M
-
-4.20M
Other non operating income
-520.00K
-42.00K
-
73.00K
EBT including unusual items
-7.36M
-8.50M
-
-14.64M
EBT excluding unusual items
-7.36M
-7.58M
-
-3.26M
Income tax expense
-236.00K
-174.00K
-
153.00K
Effective tax rate
3.21%
2.05%
-
-1.04%
Other operating expenses
-
-
-
-
Net income
-7.13M
-8.32M
-
-16.16M
Net profit margin
-8.72%
-9.78%
-
-20.93%
Earnings per share
-0.15
-0.14
-
-0.02
Interest and investment income
1.16M
880.00K
-
870.00K
Interest expense
-
-
-
-
Net interest expenses
1.16M
880.00K
-
870.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-4.27M
-3.52M
-
-2.00M
Gain or loss from assets sale
572.00K
563.00K
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
Google apps